Modelling approaches to dose estimation in children
- 7 June 2005
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 59 (6) , 663-669
- https://doi.org/10.1111/j.1365-2125.2005.02429.x
Abstract
Most of the drugs on the market are originally developed for adults and dosage selection is based on an optimal balance between clinical efficacy and safety. The aphorism 'children are not small adults' not only holds true for the selection of suitable drugs and dosages for use in children but also their susceptibility to adverse drug reactions. Since children may not be subject to dose escalation studies similar to those carried out in the adult population, some initial estimation of dose in paediatrics should be obtained via extrapolation approaches. However, following such an exercise, well-conducted PK-PD or PK studies will still be needed to determine the most appropriate doses for neonates, infants, children and adolescents.Keywords
This publication has 28 references indexed in Scilit:
- Physiologically Based Pharmacokinetic (PBPK) Modeling of Caffeine and Theophylline in Neonates and Adults: Implications for Assessing Children's Risks from Environmental AgentsJournal of Toxicology and Environmental Health, Part A, 2004
- Inter‐individual variability in levels of human microsomal protein and hepatocellularity per gram of liverBritish Journal of Clinical Pharmacology, 2003
- Physiological Modeling of Age-Specific Changes in the Pharmacokinetics of Organic Chemicals in ChildrenJournal of Toxicology and Environmental Health, Part A, 2003
- An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuriaBritish Journal of Clinical Pharmacology, 2002
- Statins and the risk of idiopathic venous thromboembolismBritish Journal of Clinical Pharmacology, 2002
- Ontogeny of Hepatic and Renal Systemic Clearance Pathways in InfantsClinical Pharmacokinetics, 2002
- Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese childrenClinical Pharmacology & Therapeutics, 2000
- Prediction of Hepatic Clearance from Microsomes, Hepatocytes, and Liver SlicesDrug Metabolism Reviews, 1997
- How many patients and blood levels are necessary for population pharmacokinetic analysis?European Journal of Clinical Pharmacology, 1996
- Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α-hydroxymidazolam in healthy volunteersClinical Pharmacology & Therapeutics, 1992